Industry
Trump Nominates Overton to Lead FDA
President Trump has nominated Heidi Overton, MD, currently deputy director of the White House Domestic Policy Council and a veteran of the America First think tank, to serve as FDA Commissioner. The nomination requires Senate confirmation. If confirmed, Overton would oversee the agency responsible for drug approvals, safety monitoring, and regulatory oversight affecting Medicaid pharmacy benefits, including biosimilar approvals and drug supply chain policies. The nomination comes as states and managed care plans manage rising prescription drug costs.
Why it mattersFDA leadership influences drug approval timelines, biosimilar availability, and safety policies that directly affect Medicaid pharmacy budgets and formulary management.